Post-vaccination adverse reactions, decision regret, and willingness to pay for the booster dose of COVID-19 vaccine among healthcare workers: A mediation analysis

References

• İ̇pek S, Yurttutan S, Güllü U, Dalkıran T, Acıpayam C, Doğaner A. Is N95 face mask linked to dizziness and headache? Int Arch Occup Environ Health. 2021;94(7):1–8. doi:10.1007/s00420-021-01665-3.
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382(13):1199–207. doi:10.1056/NEJMoa2001316.
   PubMed Web of Science ®Google Scholar
• Harapan H, Itoh N, Yufika A, Winardi W, Keamg S, Te H, Megawati D, Hayati Z, Wagner AL, Mudatsir M. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667–73. doi:10.1016/j.jiph.2020.03.019.
   PubMed Web of Science ®Google Scholar
• Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–34. doi:10.1016/S1473-3099(20)30120-1.
   PubMed Web of Science ®Google Scholar
• Majumder J, Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 2021;23(1):14. doi:10.1208/s12248-020-00532-2.
   PubMed Web of Science ®Google Scholar
• Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. J Am Med Assoc. 2020;324(8):782–93. doi:10.1001/jama.2020.12839.
   PubMed Web of Science ®Google Scholar
• Polack F, Thomas S, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Russell F, Greenwood B. Who should be prioritised for COVID-19 vaccination? Hum Vaccin Immunother. 2021;17(5):1317–21. doi:10.1080/21645515.2020.1827882.
   PubMed Web of Science ®Google Scholar
• Palacios R, Patiño E, de Oliveira R, Conde M, Batista A, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF, et al. Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (inactivated) vaccine manufactured by Sinovac - PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):853. doi:10.1186/s13063-020-04775-4.
   PubMed Web of Science ®Google Scholar
• Ullah I, Lin C-Y, Malik NI, Wu T-Y, Araban M, Griffiths MD, Pakpour AH. Factors affecting Pakistani young adults’ intentions to uptake COVID-19 vaccination: an extension of the theory of planned behavior. Brain Behav. 2021;11(11):e2370. doi:10.1002/brb3.2370.
   PubMed Web of Science ®Google Scholar
• Yahaghi R, Ahmadizade S, Fotuhi R, Taherkhani E, Ranjbaran M, Buchali Z, Jafari R, Zamani N, Shahbazkhania A, Simiari H, et al. Fear of COVID-19 and perceived COVID-19 infectability supplement theory of planned behavior to explain Iranians’ intention to get COVID-19 vaccinated. Vaccines. 2021;9(7):684. doi:10.3390/vaccines9070684.
   PubMed Web of Science ®Google Scholar
• Fan C-W, Chen I-H, Ko N-Y, Yen C-F, Lin C-Y, Griffiths MD, Pakpour AH. Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study. Hum Vaccines Immunother. 2021;17(10):3413–20. doi:10.1080/21645515.2021.1933687.
   PubMed Web of Science ®Google Scholar
• Huang P-C, Hung C-H, Kuo Y-J, Chen Y-P, Ahorsu DK, Yen C-F, Lin C-Y, Griffiths MD, Pakpour AH. Expanding protection motivation theory to explain willingness of COVID-19 vaccination uptake among Taiwanese university students. Vaccines. 2021;9(9):1046. doi:10.3390/vaccines9091046.
   PubMed Web of Science ®Google Scholar
• Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother. 2020;16(9):2204–14. doi:10.1080/21645515.2020.1790279.
   PubMed Web of Science ®Google Scholar
• Fan C-W, Chen J-S, Addo F-M, Adjaottor ES, Amankwaah GB, Yen C-F, Ahorsu DK, Lin C-Y. Examining the validity of the drivers of COVID-19 vaccination acceptance scale using rasch analysis. Expert Rev Vaccines. 2022;21(2):253–60. doi:10.1080/14760584.2022.2011227.
   PubMed Web of Science ®Google Scholar
• Yeh Y-C, Chen I-H, Ahorsu DK, Ko N-Y, Chen K-L, Li P-C, Yen C-F, Lin C-Y, Griffiths MD, Pakpour AH. Measurement invariance of the drivers of COVID-19 vaccination acceptance scale: comparison between Taiwanese and mainland Chinese-speaking populations. Vaccines. 2021;9(3):297. doi:10.3390/vaccines9030297.
   PubMed Web of Science ®Google Scholar
• Chen I-H, Wu P-L, Yen C-F, Ullah I, Shoib S, Zahid SU, Bashir A, Iqbal N, Addo F-M, Adjaottor ES, et al. Motors of COVID-19 vaccination acceptance scale (MoVac-COVID19S): evidence of measurement invariance across five countries. risk Manag Healthc Policy. 2022;15:435–45. doi:10.2147/RMHP.S351794.
   PubMed Web of Science ®Google Scholar
• Pramukti I, Strong C, Chen I-H, Yen C-F, Rifai A, Ibrahim K, Pandin MGR, Subramaniam H, Griffiths MD, Lin C-Y, et al. The motors of COVID-19 vaccination acceptance scale (MoVac-COVID19S): measurement invariant evidence for its nine-item version in Taiwan, Indonesia, and Malaysia. Psychol Res Behav Manag. 2022;15:1617–25. doi:10.2147/PRBM.S363757.
   PubMed Web of Science ®Google Scholar
• Chen I-H, Ahorsu DK, Ko N-Y, Yen C-F, Lin C-Y, Griffiths MD, Pakpour AH. Adapting the motors of influenza vaccination acceptance scale into the motors of COVID-19 vaccination acceptance scale: psychometric evaluation among mainland Chinese university students. Vaccine. 2021;39(32):4510–15. doi:10.1016/j.vaccine.2021.06.044.
   PubMed Web of Science ®Google Scholar
• He S, Anderson E. Conceptualizing and measuring pathways for how object attachment affects willingness to pay (WTP). Curr Opin Psychol. 2021;39:121–24. doi:10.1016/j.copsyc.2020.09.008.
   PubMed Web of Science ®Google Scholar
• Shih H, Chou P, Chen S, Liu J, Lee F, Liu C, Tung T-H. A community-based study of the willingness to pay associated with screening for diabetic retinopathy among type 2 diabetes in Kinmen, Taiwan. J Epidemiol. 2007;17(6):186–93. doi:10.2188/jea.17.186.
   PubMed Web of Science ®Google Scholar
• Miller K, Hofstetter R, Krohmer H, Zhang Z. How should consumers’ willingness to pay be measured? An empirical comparison of state-of-the-art approaches. J Mark Res. 2011;48(1):172–84. doi:10.1509/jmkr.48.1.172.
   Web of Science ®Google Scholar
• Dias-Godói I, Tadeu Rocha Sarmento T, Afonso Reis E, Peres Gargano L, Godman B, de Assis Acurcio F, Alvares-Teodoro J, Guerra Júnior AA, Mariano Ruas C. Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications. Expert Rev Pharmacoecon Outcomes Res. 2022;22(1):119–29. doi:10.1080/14737167.2021.1931128.
   PubMed Web of Science ®Google Scholar
• Vaishya R, Sibal A, Malani A, Prasad K. SARS-CoV-2 infection after COVID-19 immunization in healthcare workers: a retrospective, pilot study. Indian J Med Res. 2021;153(5):550–54. doi:10.4103/ijmr.ijmr_1485_21.
   PubMed Web of Science ®Google Scholar
• Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin EG, Rubin C, Indenbaum V, et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021;385(16):1474–84. doi:10.1056/NEJMoa2109072.
   PubMed Web of Science ®Google Scholar
• Naaber P, Tserel L, Kangro K, Sepp E, Jürjenson V, Adamson A, Haljasmägi L, Rumm AP, Maruste R, Kärner J, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg Health Eur. 2021;10:100208. doi:10.1016/j.lanepe.2021.100208.
   PubMedGoogle Scholar
• Dong Y, Dai T, Wei Y, Zhang L, Zheng M, Zhou F. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduct Target Ther. 2020;5(1):237. doi:10.1038/s41392-020-00352-y.
   PubMed Web of Science ®Google Scholar
• Jalkanen P, Kolehmainen P, Häkkinen H, Huttunen M, Tähtinen P, Lundberg R, Maljanen S, Reinholm A, Tauriainen S, Pakkanen SH, et al. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat Commun. 2021;12(1):3991. doi:10.1038/s41467-021-24285-4.
   PubMed Web of Science ®Google Scholar
• Sabetian G, Moghadami M, Hashemizadeh Fard Haghighi L, Shahriarirad R, Fallahi M, Asmarian N, Moeini YS. COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran. Virol J. 2021;18(1):58. doi:10.1186/s12985-021-01532-0.
   PubMed Web of Science ®Google Scholar
• Zheng L, Wang X, Zhou C, Liu Q, Li S, Sun Q, Wang M, Zhou Q, Wang W. Analysis of the infection status of healthcare workers in Wuhan during the COVID-19 outbreak: a cross-sectional study. Clin Infect Dis. 2020;71(16):2109–13. doi:10.1093/cid/ciaa588.
   PubMed Web of Science ®Google Scholar
• Kukreti S, Lu M-Y, Lin Y-H, Strong C, Lin C-Y, Ko N-Y, Chen P-L, Ko W-C. Willingness of Taiwan’s healthcare workers and outpatients to vaccinate against COVID-19 during a period without community outbreaks. Vaccines. 2021;9(3):246. doi:10.3390/vaccines9030246.
   PubMed Web of Science ®Google Scholar
• Kotecha IS, Vasavada DA, Kumar P, Nerli LM, Tiwari DS, Parmar DV. Knowledge, attitude, and belief of health-care workers toward COVID-19 vaccine at a tertiary care center in India. Asian J Soc Health Behav. 2022;5(2):63–67. doi:10.4103/shb.shb_20_21.
   Google Scholar
• Rad MK, Fakhri A, Stein L, Araban M. Health-care staff beliefs and coronavirus disease 2019 vaccinations: a cross-sectional study from Iran. Asian J Soc Health Behav. 2022;5(1):40–46. doi:10.4103/shb.shb_13_22.
   Google Scholar
• Maruyama A, Sawa T, Teramukai S, Katoh N. Adverse reactions to the first and second doses of Pfizer-BioNtech COVID-19 vaccine among healthcare workers. J Infect Chemother. 2022;28(7):934–42. S1341-321X(22)00094-0. doi:10.1016/j.jiac.2022.03.015.
   PubMed Web of Science ®Google Scholar
• Kałucka S, Kusideł E, Głowacka A, Oczoś P, Grzegorczyk-Karolak I. Pre-vaccination stress, post-vaccination adverse reactions, and attitudes towards vaccination after receiving the COVID-19 vaccine among health care workers. Vaccines (Basel). 2022;10(3):401. doi:10.3390/vaccines10030401.
   PubMed Web of Science ®Google Scholar
• Zikmund-Fisher B, Couper M, Singer E, Levin C, Fowler FJ, Ziniel S, Ubel PA, Fagerlin A. The DECISIONS study: a nationwide survey of United States adults regarding 9 common medical decisions. Med Decis Making. 2010;30(5 Suppl):20S–34S. doi:10.1177/0272989X09353792.
   PubMedGoogle Scholar
• O’Connor A, Drake E, Wells G, Tugwell P, Laupacis A, Elmslie T. A survey of the decision-making needs of Canadians faced with complex health decisions. Health Expect. 2003;6(2):97–109. doi:10.1046/j.1369-6513.2003.00215.x.
   PubMedGoogle Scholar
• Becerra Pérez M, Menear M, Brehaut J, Légaré F. Extent and predictors of decision regret about health care decisions: a systematic review. Med Decis Making. 2016;36(6):777–90. doi:10.1177/0272989X16636113.
   PubMed Web of Science ®Google Scholar
• Luo C, Chen H, Tung T. COVID-19 vaccination in China: adverse effects and its impact on health care working decisions on booster dose. Vaccines (Basel). 2022;10(8):1229. doi:10.3390/vaccines10081229.
   PubMed Web of Science ®Google Scholar
• Haun M, Schakowski A, Preibsch A, Friederich H, Hartmann M. Assessing decision regret in caregivers of deceased German people with cancer-A psychometric validation of the decision regret scale for caregivers. Health Expect. 2019;22(5):1089–99. doi:10.1111/hex.12941.
   PubMed Web of Science ®Google Scholar
• Tung T, Lin X, Chen Y, Zhang M, Zhu J. Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China. Hum Vaccin Immunother. 2022;2099210. doi:10.1080/21645515.2022.2099210.
   PubMed Web of Science ®Google Scholar
• Judd C, Kenny D. Process analysis: estimating mediation in treatment evaluations. Eval Rev. 1981;5(5):602–19. doi:10.1177/0193841X8100500502.
   Web of Science ®Google Scholar
• Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Soc Methodol. 1982;13(13):290–312. doi:10.2307/270723.
   Google Scholar
• Voysey M, Costa Clemens S, Madhi S, Weckx L, Folegatti P, Aley P, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdox1 nCov-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881–91. doi:10.1016/S0140-6736(21)00432-3.
   PubMed Web of Science ®Google Scholar
• Ramasamy M, Minassian A, Ewer K, Flaxman A, Folegatti P, Owens D, Voysey M, Aley PK, Angus B, Babbage G, et al. Safety and immunogenicity of ChAdox1 nCov-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021;396(10267):1979–93. doi:10.1016/S0140-6736(20)32466-1.
   PubMed Web of Science ®Google Scholar
• Yigit M, Ozkaya-Parlakay A, Cosgun Y, Ince Y, Bulut Y, Senel E. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience. J Med Virol. 2022;94(1):287–90. doi:10.1002/jmv.27318.
   PubMed Web of Science ®Google Scholar